FrancophonIA/ELRC3.0 huggingface dataset:
English: The safety and efficacy of epoetin alfa in paediatric patients receiving chemotherapy have not been established (see section 5.1).
Danish: Epoetin alfas sikkerhed og virkning hos pædiatriske patienter, der får kemoterapi, er ikke klarlagt (se pkt.
English: Retacrit is indicated in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre-existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.
Danish: Retacrit er indiceret til voksne, der får kemoterapi for solide tumorer, malignt lymfom eller myelomatose og ved risiko ved transfusion pga. patientens almentilstand (f.eks kardiovaskulær tilstand, præeksisterende anæmi ved kemoterapistart) til behandling af anæmi og til nedsættelse af transfusionsbehov.
English: • Your doctor will order blood tests, and may adjust the dose, depending on how your anaemia responds to Retacrit treatment.
Danish: • Din læge bestiller blodprøver og vil måske justere dosis, afhængigt af hvordan din blodmangel reagerer på behandling med Retacrit.
English: In a double-blind, placebo-controlled, multicentre, quality of life study in CRF patients on haemodialysis, clinically and statistically significant improvement was shown in the patients treated with epoetin alfa compared to the placebo group when measuring fatigue, physical symptoms, relationships and depression (Kidney Disease Questionnaire) after six months of therapy.
Danish: I et dobbeltblindet, placebokontrolleret multicenterstudie af livskvalitet hos dialyse patienter med kronisk nyresvigt sås klinisk og statistisk signifikant bedring hos de patienter, der blev behandlet med epoetin alfa, sammenlignet med placebogruppen, ved måling af træthed, fysiske symptomer, sociale relationer og depression (spørgeskema for nyresygdom) efter seks måneders behandling.
English: Significantly fewer patients received RBC transfusions in the epoetin alfa plus SOC arm (5.8% versus 11.4%); however, significantly more patients had thrombotic vascular events in the epoetin alfa plus SOC arm (2.8% versus 1.4%).
Danish: Signifikant færre patienter fik erytocyttransfusioner i epoetin alfa plus standardbehandlingsgruppen (5,8 % mod 11,4 %); men der var signifikant flere patienter, der havde trombotiske vaskulære hændelser i epoetin alfa plus standardbehandlingsgruppen (2,8 % versus 1,4 %).
English: All other causes of anaemia (iron, folate or Vitamin B12 deficiency, aluminium intoxication, infection or inflammation, blood loss, haemolysis and bone marrow fibrosis of any origin) should be evaluated and treated prior to initiating therapy with epoetin zeta, and when deciding to increase the dose.
Danish: Alle andre årsager til anæmi (jern-, folinsyre- eller B12-vitaminmangel, aluminiumforgiftning, infektion eller inflammation, blodtab, hæmolyse og knoglemarvsfibrose uanset årsag) skal udredes og behandles, inden behandlingen med epoetin zeta påbegyndes, og når det besluttes at øge dosis.
English: Good blood management practices should always be used in the perisurgical setting.
Danish: Perioperativt bør der altid sørges for god blodbehandlingspraksis.
English: After single doses (20 000 to 160 000 IU subcutaneously) of epoetin alfa, a dose-dependent response was observed for the pharmacodynamic markers investigated including: reticulocytes, RBCs, and haemoglobin.
Danish: Efter enkeltdoser epoetin alfa (20.000-160.000 IE subkutant) observeredes et dosisafhængigt respons for de undersøgte farmakodynamiske markører, herunder retikulocytter, erytrocytter og hæmoglobin.
English: For patients in an autologous predonation programme, iron supplementation (elemental iron 200 mg/day orally) should be administered several weeks prior to initiating the autologous predeposit in order to achieve high iron stores prior to starting epoetin zeta therapy, and throughout the course of epoetin zeta therapy.
Danish: Til patienter, der indgår i et autologt prædonationsprogram, bør jerntilskud (elementært jern 200 mg/dag oralt) administreres flere uger før indledning af den autologe prædonation for at opnå høje jerndepoter inden behandlingen med epoetin zeta, samt under hele behandlingsforløbet.
English: In the open-label study there was no difference in overall survival between patients treated with recombinant human erythropoietin and controls.
Danish: I det åbne studie var der ingen forskel i den samlede overlevelse mellem patienter behandlet med rekombinant humant erythropoietin og kontrolgruppen.
English: A major cardiovascular event (death, myocardial infarction, stroke or hospitalization for congestive heart failure) occurred among 125 (18%) of the 715 patients in the higher haemoglobin group compared to 97 (14%) among the 717 patients in the lower haemoglobin group (hazard ratio [HR] 1.3, 95% CI: 1.0, 1.7, p = 0.03).
Danish: Der indtraf en større kardiovaskulær hændelse (død, myokardieinfarkt, apopleksi eller indlæggelse pga. hjerteinsufficiens) blandt 125 (18 %) af de 715 patienter i gruppen med højere hæmoglobinværdier sammenlignet med 97 (14 %) blandt de 717 patienter i gruppen med lavere hæmoglobinværdier (hazard ratio [HR] 1,3; 95 % CI: 1,0; 1,7, p =
English: In clinical trials, an increased risk of death and serious cardiovascular events was observed when ESAs were administered to achieve a haemoglobin concentration level of greater than 12 g/dL (7.5 mmol/L).
Danish: I kliniske studier blev der observeret en øget risiko for dødsfald og alvorlige kardiovaskulære hændelser, når ESA'er blev administreret for at nå en hæmoglobinkoncentration på mere end 12 g/dl (7,5 mmol/l).
English: Retacrit should be administered by the intravenous route.
Danish: Retacrit skal administreres intravenøst.
English: Together, these two components comprise the needle-trap (safety) feature.
Danish: Tilsammen udgør de to komponenter nålefanget.
English: • The starting dose is either 150 IU per kilogram bodyweight three times a week or 450 IU per kilogram bodyweight once a week.
Danish: • Startdosen er enten 150 IE pr. kilogram legemsvægt 3 gange om ugen eller 450 IE pr. kilogram legemsvægt 1 gang om ugen.
English: The recommended maintenance dose is between 25 IU/kg and 50 IU/kg, 2 times per week in 2 equal injections.
Danish: Den anbefalede vedligeholdelsesdosis er mellem 25 og 50 IE/kg 2 gange ugentligt fordelt på 2 lige store injektioner.
English: Where intravenous access is not readily available Retacrit may be administered subcutaneously.
Danish: Hvor der ikke er anlagt intravenøs adgang, kan Retacrit administreres subkutant.
English: Do not try to replace the needle cover.
Danish: Forsøg ikke at sætte nålebeskyttelseshætten på igen.
English: Take special care with Retacrit
Danish: Vær særligt forsigtig med Retacrit
English: • Push the needle in fully.
Danish: • Træk nålen ud.
English: The half-life for the subcutaneous route is estimated to be approximately 24 hours in healthy subjects.
Danish: Efter subkutan administration estimeres halveringstiden til at være ca. 24 timer hos raske forsøgspersoner.
English: Epoetin alfa has been studied in clinical trials in adult anaemic CRF patients, including haemodialysis and pre-dialysis patients, to treat anaemia and maintain haematocrit within a target concentration range of 30 to 36%.
Danish: Epoetin alfa er blevet undersøgt i kliniske studier hos voksne anæmiske patienter med kronisk nyresvigt, herunder dialyse- og prædialysepatienter, til at behandle anæmi og vedligeholdelse af hæmatokrit inden for det anbefalede koncentrationsinterval på 30-36 %.
English: The effect of epoetin alfa (300 IU/kg or 100 IU/kg) on the exposure to allogeneic blood transfusion has been evaluated in a placebo-controlled, double-blind clinical trial in non-iron deficient adult patients scheduled for major elective orthopaedic hip or knee surgery.
Danish: Virkningen af epoetin alfa (300 IE/kg eller 100 IE/kg) på eksponeringen for allogen blodtransfusion blev evalueret i et placebokontrolleret, dobbeltblindet klinisk studie hos voksne patienter uden jernmangel, som var planlagt til en større elektiv ortopædisk hofte- eller knæoperation.
English: Retacrit is indicated for non-iron deficient adults prior to major elective orthopaedic surgery having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.
Danish: • Retacrit er indiceret til voksne uden jernmangel forud for større elektive ortopædkirurgiske operationer, hvor der er formodning om en høj risiko for transfusionskomplikationer, til at nedsætte brugen af allogene blodtransfusioner.
English: • an observed 9% increase in risk for PD or death in the epoetin zeta plus SOC group from a primary analysis and a 15% increased risk that cannot be statistically ruled out in patients with metastatic breast cancer receiving chemotherapy when administered to achieve a haemoglobin concentration range of 10 to 12 g/dL (6.2 to 7.5 mmol/L).
Danish: • en observeret 9 % stigning i risikoen for sygdomsprogression eller død i gruppen, der blev behandlet med epoetin zeta plus standardbehandling, i en primær analyse, samt en 15 % øget risiko, der ikke statistisk kan udelukkes, for patienter med metastatisk brystcancer, der fik kemoterapi, når det administreredes for at opnå en hæmoglobinkoncentration på 10-12 g/dl (6,2-7,5 mmol/l).
English: Epoetin alfa was administered at 75 IU/kg/week intravenously in 2 or 3 divided doses post-dialysis, titrated by 75 IU/kg/week at intervals of 4 weeks (up to a maximum of 300 IU/kg/week), to achieve a 1 g/dL/month increase in haemoglobin.
Danish: Epoetin alfa 75 IE/kg blev administreret intravenøst fordelt på 2 eller 3 doser efter dialysen og blev titreret med 75 IE/kg/uge med 4 ugers interval (op til maksimalt 300 IE/kg/uge) for at opnå en stigning i hæmoglobin på 1 g/dl/måned.
English: Instructions on how to inject Retacrit yourself
Danish: Vejledning i, hvordan du kan give dig selv indsprøjtninger med Retacrit
English: Epoetin alfa administered 3 times per week or once weekly has been shown to increase haemoglobin and decrease transfusion requirements after the first month of therapy in anaemic cancer patients receiving chemotherapy.
Danish: Epoetin alfa administreret 3 gange ugentligt eller én gang ugentligt har vist sig at øge hæmoglobin og nedsætte behovet for transfusioner efter den første måneds behandling hos anæmiske cancerpatienter, der får kemoterapi.
English: A rise in haemoglobin of greater than 2 g/dL over a four week period should be avoided.
Danish: En stigning i hæmoglobin på mere end 2 g/dl over en 4 ugers periode skal undgås.
English: Overall survival outcome in the trials could not be satisfactorily explained by differences in the incidence of thrombosis and related complications between those given recombinant human erythropoietin and those in the control group.
Danish: Den samlede overlevelse i studierne kunne ikke fyldestgørende forklares ved forskellene i hyppigheden af trombose og relaterede komplikationer mellem de patienter, der fik rekombinant humant erythropoietin og de patienter, der var i kontrolgruppen.
English: In these studies, most were predialysis patients (N=44), 27 patients were on peritoneal dialysis and 2 were on haemodialysis with age ranging from 4 months to 17 years.
Danish: I disse studier var de fleste patienter prædialysepatienter (N = 44), 27 patienter var i peritonealdialyse og 2 fik hæmodialyse.
English: Chills, Influenza like illness, Injection site reaction, Oedema peripheral
Danish: Kuldegysninger, influenzalignende symptomer, reaktioner på injektionsstedet, perifere ødemer
English: In healthy subjects, a dose-proportional increase in serum erythropoietin concentrations was observed after intravenous administration of 150 and 300 IU/kg, 3 times per week.
Danish: Hos raske forsøgspersoner observeredes en dosisproportional stigning i serumkoncentrationen af epoetin efter intravenøs administration af 150 og 300 IE/kg 3 gange ugentligt.
English: Retacrit is not approved in the management of anaemia associated with hepatitis C.
Danish: Retacrit er ikke godkendt til behandling af blodmangel, der er forbundet med hepatitis C.
English: Alternatively, Retacrit can be administered at an initial dose of 450 IU/kg subcutaneously once weekly.
Danish: Alternativt kan Retacrit administreres subkutant med en startdosis på 450 IE/kg 1 gang ugentligt.
English: An open-label, parallel-group trial in non-iron deficient adult subjects with a pretreatment haemoglobin of ≥ 10 to ≤ 13 g/dL who were scheduled for major orthopaedic hip or knee surgery compared epoetin alfa 300 IU/kg subcutaneously daily for 10 days prior to surgery, on the day of surgery and for four days after surgery to epoetin alfa 600 IU/kg subcutaneously once weekly for 3 weeks prior to surgery and on the day of surgery.
Danish: I et åbent parallelgruppestudie af voksne forsøgspersoner uden jernmangel med hæmoglobin før behandling på ≥ 10 til ≤ 13 g/dl og som skulle gennemgå en planlagt større ortopædisk hofte- eller knæoperation, blev epoetin alfa 300 IE/kg subkutant dagligt i 10 dage før operationen, på operationsdagen og i fire dage efter operationen sammenlignet med epoetin alfa 600 IE/kg subkutant ugentligt i 3 uger før operationen og på operationsdagen.
English: In chronic renal failure patients the rate of increase in haemoglobin should be approximately 1 g/dL (0.62 mmol/L) per month and should not exceed 2 g/dL (1.25 mmol/L) per month to minimise risks of an increase in hypertension.
Danish: Hos patienter med kronisk nyresvigt bør hastigheden af stigningen i hæmoglobin være ca. 1 g/dl (0,62 mmol/l) pr. måned og bør ikke overstige 2 g/dl (1,25 mmol/l) pr. måned for at minimere risikoen for forværring af hypertension.
English: Antibody-mediated pure red cell aplasia (PRCA) has been reported after months to years of treatment with epoetins.
Danish: Antistof-forårsaget aplasi med umodne erytrocytter (pure red cell aplasia PRCA)) er rapporteret efter måndeders eller års behandling med epoetiner.
English: Anaemia in chronic renal failure patients before initiation of dialysis or on peritoneal dialysis
Danish: Anæmi hos patienter med kronisk nyresvigt før indledning af dialyse eller i peritonealdialyse
English: If you get any side effects, talk to your doctor, nurse or pharmacist.
Danish: Hvis du oplever bivirkninger, bør du tale med din læge, sygeplejerske eller apotekspersonalet.
English: In most anaemic subjects with cancer receiving cyclic chemotherapy CL/F was lower after subcutaneous doses of 40 000 IU once weekly and 150 IU/kg, 3 times per week compared with the values for healthy subjects.
Danish: Hos de fleste anæmiske forsøgspersoner med cancer, der fik serier med kemoterapi, var CL/F lavere efter subkutane doser på 40.000 IE en gang ugentligt og 150 IE/kg 3 gange ugentligt sammenlignet med værdierne hos raske forsøgspersoner.
English: • Your doctor will maintain your haemoglobin level between 10 and 12 g/dL as a high haemoglobin level may increase the risk of blood clots and death.
Danish: • Din læge vil opretholde dit hæmoglobinniveau på mellem 10 og 12 g/dl, da et højere hæmoglobinniveau kan øge risikoen for blodpropper og dødsfald.
English: In patients with a poor haemoglobin response to ESA, alternative explanations for the poor response should be considered (see sections 4.4 and 5.1).
Danish: Hos patienter med et dårligt hæmoglobinrespons på ESA, bør alternative forklaringer på det dårlige respons overvejes (se pkt.
English: The solution contains 3 333 IU epoetin zeta per ml.
Danish: Opløsningen indeholder 3.333 IE epoetin zeta pr. ml.
English: No data on the effects of epoetin zeta on fertility are available.
Danish: Der findes ikke tilgængelige data om epoitin zetas virkning på fertiliteten.
English: • If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby,
Danish: • Hvis du er gravid eller ammer, har mistanke om, at du er gravid, eller planlægger at blive gravid, skal du spørge din læge eller apotekspersonalet til råds, før du bruger dette lægemiddel.
English: The safety and efficacy of Retacrit in chronic renal failure patients with anaemia before initiation of dialysis or on peritoneal dialysis have not been established.
Danish: Retacrits sikkerhed og virkning hos patienter med kronisk nyresvigt med anæmi før indledning af dialyse eller ved peritonealdialyse er ikke klarlagt.
English: Retacrit has no or negligible influence on the ability to drive and use machines.
Danish: Retacrit har ingen eller ringe indflydelse på evnen til at føre motorkøretøj eller betjene maskiner.
English: Do not shake Retacrit syringes.
Danish: Ryst ikke sprøjterne med Retacrit.
English: The safety and efficacy of epoetin alfa in paediatrics have not been established.
Danish: Epoetin alfas sikkerhed og virkning hos pædiatriske patienter er ikke klarlagt.
English: • Retacrit is used to treat anaemia in adults with a bone marrow disorder that causes a severe disruption in the creation of blood cells (myelodysplastic syndromes).
Danish: • Retacrit bruges til at behandle blodmangel hos voksne med en knoglemarvssygdom, der giver alvorlige problemer med dannelsen af blodlegemer (myelodysplastisk syndrom).
English: Antibody-mediated pure red cell aplasia has been very rarely reported in <1/10 000 cases per patient year after months to years of treatment with epoetins (see section 4.4).
Danish: Der foreligger sjældne rapporter om antistof-forårsaget pure red cell aplasia (PRCA) i < 1/10.000 tilfælde pr. patientår efter måneders eller års behandling med epoetiner (se pkt.
English: A less defined profile was observed for RBCs and haemoglobin.
Danish: Der sås en mindre veldefineret profil for erytrocytter og hæmoglobin.
English: In a study comparing the 150 IU/kg, 3 times-per-week and 40 000 IU, once-weekly dosing regimens in healthy subjects and in anaemic cancer subjects the time profiles of changes in percent reticulocytes, haemoglobin, and total red blood cells were similar between the two dosing regimens in both healthy and anaemic cancer subjects.
Danish: I et studie, der sammenlignede dosisregimer med 150 IE/kg 3 gange ugentligt og 40.000 IE én gang ugentlig hos raske forsøgspersoner og hos anæmiske forsøgspersoner med cancer, var tidsprofilerne for ændring i procent af retikulocytter, hæmoglobin og totalt erytrocyttal sammenlignelige mellem de to dosisregimer, hos såvel raske personer som anæmiske forsøgspersoner med cancer.
English: • Do not hold by the plunger head, plunger or needle cover.
Danish: • Hold ikke ved stempelhovedet, stemplet eller ved nålebeskyttelseshætten.
English: Patients should be monitored closely to ensure that the lowest approved dose of Retacrit is used to provide adequate control of anaemia and of the symptoms of anaemia.
Danish: Patienterne bør monitoreres nøje for at sikre at den laveste godkendte dosis Retacrit anvendes til at opnå tilstrækkelig kontrol med anæmien og de anæmiske symptomer.
English: Very common: may affect more than 1 in 10 people.
Danish: Meget almindelige: Forekommer hos flere end 1 ud af 10 patienter.
English: Your doctor or nurse may have shown you how to do this.
Danish: • Tryk nålen helt ind. Din læge eller sygeplejerske har vist dig, hvordan det skal gøres.
English: If the haemoglobin level reaches 15 g/dL (9.38 mmol/L), or higher, during the preoperative period, administration of Retacrit should be stopped and further dosages should not be administered.
Danish: Hvis koncentrationen af hæmoglobin når 15 g/dl (9,38 mmol/l) eller derover i perioden op til operationen, skal administration af Retacrit stoppes, og der må ikke administreres flere doser.
English: There was no accumulation after multiple dose administration of 600 IU/kg administered subcutaneously weekly.
Danish: Der forekom ingen akkumulering efter subkutan administration af gentagne doser på 600 IE/kg om ugen.
English: From pretreatment to presurgery, the mean increase in haemoglobin in the 600 IU/kg weekly group (1.44 g/dL) was twice than that observed in the 300 IU/kg daily group (0.73 g/dL).
Danish: Fra før behandlingen til før operationen var den gennemsnitlige stigning i hæmoglobin i gruppen, der fik 600 IE/kg ugentligt (1,44 g/dl), dobbelt så stor som den, der blev observeret i gruppen, der fik 300 IE/kg dagligt (0,73 g/dl).
English: Paediatric patients with very low initial haemoglobin (<6.8 g/dL or <4.25 mmol/L) may require higher maintenance doses than patients whose initial haemoglobin is higher (>6.8 g/dL or >4.25 mmol/L).
Danish: Pædiatriske patienter med meget lavt initialt hæmoglobin (< 6,8 g/dl eller < 4,25 mmol/l) kan have behov for højere vedligeholdelsesdoser end patienter, hvis initiale hæmoglobin er højere (> 6,8 g/dl eller > 4,25 mmol/l).
English: • decreased locoregional control in patients with advanced head and neck cancer receiving radiation therapy when administered to achieve a haemoglobin concentration level of greater than 14 g/dL (8.7 mmol/L),
Danish: • nedsat lokoregional kontrol hos patienter med fremskreden hoved- og halscancer, der får strålebehandling, når det administreres for at opnå en hæmoglobinkoncentration på mere end 14 g/dl (8,7 mmol/l),
English: •Retacrit is used to treat anaemia in adultsreceiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion.
Danish: •Retacrit bruges til at behandle blodmangel hosvoksne, som behandles med kemoterapi for fastetumorer, ondartet tumor i lymfekirtel (malignt lymfom)eller multipelt myelom (knoglemarvskræft), som kan have brug for blodtransfusion.
English: Epoetin zeta should be used with caution in nursing women.
Danish: Epoetin zeta bør anvendes med forsigtighed til ammende kvinder.
English: Epoetin zeta should be used with caution in patients with chronic liver failure.
Danish: Epoetin zeta skal anvendes med forsigtighed til patienter med kronisk leversvigt.
English: A tendency towards increased risk estimates for all-cause mortality, cardiovascular and cerebrovascular events associated with higher cumulative ESA doses independent of the diabetes or dialysis status was observed (see sections 4.2 and 4.4).
Danish: Der observeredes en tendens i retning af forøgede risikoestimater for mortalitet uanset årsag, for kardiovaskulære og for cerebrovaskulære hændelser ved højere kumulative ESA-doser uafhængigt af diabetes- eller dialysestatus (se pkt.
English: For chronic renal failure patients, iron supplementation (elemental iron 200 to 300 mg/day orally for adults and 100 to 200 mg/day orally for paediatrics) is recommended if serum ferritin levels are below 100 ng/mL.
Danish: Til patienter med kronisk nyresvigt anbefales det at give jerntilskud (elementært jern 200-300 mg/dag oralt til voksne og 100-200 mg/dag oralt til børn), hvis serumferritin ligger under 100 ng/ml.
English: Other medicines and Retacrit
Danish: Brug af anden medicin sammen med Retacrit
English: The use of epoetin zeta is not recommended in pregnant surgical patients participating in an autologous blood predonation.
Danish: Epoetin zeta bør ikke anvendes til gravide kirurgiske patienter, der deltager i en autolog blodprædonation.
English: Patients with very low initial haemoglobin (<6 g/dL or <3.75 mmol/L) may require higher maintenance doses than patients whose initial anaemia is less severe (>8 g/dL or >5 mmol/L).
Danish: Patienter med meget lavt initialt hæmoglobin (< 6 g/dl eller < 3,75 mmol/l) kan have behov for højere vedligeholdelsesdoser end patienter med mindre alvorlig initial anæmi (> 8 g/dl or > 5 mmol/l).
English: In patients with a poor haemoglobin response to epoetins, alternative explanations for the poor response should be considered (see sections 4.2 and 5.1).
Danish: Hos patienter med et dårligt hæmoglobinrespons over for epoetiner skal alternative forklaringer på det dårlige respons overvejes (se pkt.
English: In order to ensure optimum response to epoetin zeta, adequate iron stores should be assured and iron supplementation should be administered if necessary (see section 4.4).
Danish: For at sikre et optimalt respons på epoetin zeta, skal det sikres, at der er tilstrækkelige jerndepoter, og om nødvendigt skal der gives jerntilskud (se pkt.